JAK2 and myeloid neoplasm: Thereby, JAK2-V617F is a frequent driver of myeloproliferative neoplasms (MPN), a group of myeloid malignancies caused by an increased proliferation and cytokine production of different myeloid cell types [11,12,13,14].